Provided by Tiger Trade Technology Pte. Ltd.

Stoke Therapeutics, Inc.

29.03
-0.3100-1.06%
Post-market: 29.030.00000.00%19:59 EDT
Volume:587.52K
Turnover:17.20M
Market Cap:1.87B
PE:-8.71
High:30.16
Open:29.82
Low:29.01
Close:29.34
52wk High:40.22
52wk Low:20.32
Shares:64.53M
Float Shares:49.01M
Volume Ratio:0.98
T/O Rate:1.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3325
EPS(LYR):-0.1163
ROE:-61.10%
ROA:-35.87%
PB:5.42
PE(LYR):-249.69

Loading ...

Stoke Therapeutics CMO Barry Ticho disposes of 2,243 shares for $73,528.97

Reuters
·
May 06

Stoke Therapeutics schedules webcast, conference call for first-quarter business and financial updates

Reuters
·
May 01

Stoke Therapeutics announces annual shareholder meeting via webcast

Reuters
·
Apr 23

BRIEF-Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Apr 17

Stoke Therapeutics grants 129,565 inducement stock options to new employees at $35.54/share

Reuters
·
Apr 17

Did Stoke's New R&D Chair Appointment Just Reshape Stoke Therapeutics' (STOK) Antisense Strategy Priorities?

Simply Wall St.
·
Apr 16

Stoke Therapeutics CEO to present at Needham Virtual Healthcare Conference

Reuters
·
Apr 09

Stoke Therapeutics appoints Clare Kahn to board of directors

Reuters
·
Apr 08

Stoke Therapeutics Appoints Clare Kahn, Ph.d., to Its Board of Directors

THOMSON REUTERS
·
Apr 08

Stoke Therapeutics CMO Barry Ticho sells STOK shares for 0.1 million

Reuters
·
Apr 04

Stoke Therapeutics FY2026 auditor changes; KPMG dismissed and EY appointed

Reuters
·
Mar 28

Stoke Therapeutics General Counsel Jonathan Allan reports STOK common stock disposal worth USD 313,000

Reuters
·
Mar 25

Stock Track | Stoke Therapeutics Soars 5.39% Intraday on Analyst Price Target Hike

Stock Track
·
Mar 20

Stoke Therapeutics Inc : Canaccord Genuity Raises Target Price to $60 From $36

THOMSON REUTERS
·
Mar 20

Stoke Therapeutics Chief Medical Officer Barry Ticho disposes of USD 460,000 in common shares

Reuters
·
Mar 20

Analysts Offer Insights on Healthcare Companies: Stoke Therapeutics (STOK), Valneva (VALN) and Protagonist Therapeutics (PTGX)

TIPRANKS
·
Mar 19

Stoke Therapeutics files automatic mixed securities shelf

TIPRANKS
·
Mar 19

Stoke Therapeutics Inc: Files for Mixed Shelf Offering; Size Not Disclosed - SEC Filing

THOMSON REUTERS
·
Mar 19

Stoke Therapeutics Inc : Wedbush Raises Target Price to $38 From $36

THOMSON REUTERS
·
Mar 18

Stoke Therapeutics director Arthur A. Levin disposes of USD 22,264 in common shares

Reuters
·
Mar 18